ADC Therapeutics SA
ADCT
$3.70
-$0.26-6.57%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 79.14% | 6.83% | -55.01% | 17.17% | 63.86% |
| Total Depreciation and Amortization | -85.75% | -84.79% | 0.24% | -4.98% | -6.38% |
| Total Amortization of Deferred Charges | 144.17% | 42.05% | 47.73% | -62.03% | -180.26% |
| Total Other Non-Cash Items | -872.19% | 11.27% | 117.15% | -2.68% | -103.08% |
| Change in Net Operating Assets | -215.48% | -95.41% | 418.47% | -197.44% | 47.41% |
| Cash from Operations | -42.43% | -18.32% | 26.66% | -27.76% | 30.92% |
| Capital Expenditure | 100.00% | 100.00% | 100.00% | 50.28% | 72.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 832.22% | 100.00% | 100.00% | 50.28% | 72.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 135,604.65% | -- | -4.73% | -23.88% | -- |
| Repurchase of Common Stock | -8.68% | 77.47% | -- | -- | -116,200.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,197.23% | 77.47% | -4.98% | -23.88% | -111,900.00% |
| Foreign Exchange rate Adjustments | 92.71% | -97.94% | 1,258.33% | 474.42% | -325.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 213.65% | -15.38% | 6.11% | -26.75% | 26.42% |